Wednesday, April 27, 2016

BRIEF-Aeterna Zentaris acquires U.S. Promotional rights for prostate cancer blood test

* Aeterna zentaris acquires exclusive u.s. Promotional

rights for apifiny prostate cancer blood test

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)